The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 356:308-311 January 18, 2007 Number 3
NextNext

Radiotherapy for Prostate Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Pisansky, T. M.
-PubMed Citation
To the Editor: In the Clinical Therapeutics article by Pisansky (Oct. 12 issue),1 intensity-modulated radiotherapy with photons and proton therapy2 are mentioned, but intensity-modulated proton therapy3 and tomotherapy are not.4 With proton therapy, intensity-modulated proton therapy, and tomotherapy, the dose of radiation delivered to nontargeted tissue is reduced,2,3,4 and intensity-modulated proton therapy even permits a reduction in the dose delivered to targeted tissue in order to spare critical structures.5 We agree with Pisansky that external-beam radiotherapy with photons is recommended for the patient in the vignette and that patients with localized prostate cancer should enroll in clinical trials. Advances in . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.